Kortikosteroidler

No hubo efectos beneficiosos obvios en: enfermedad pulmonar crónica (CR promedio 0,86; IC del 95%: 0,42 a 1,79; participantes = 818; estudios = 6; Tau² = 0,38; I² = 65%); peso promedio al nacer (g) (DM -18,47; IC del 95%: -40,83 a 3,90; participantes = 6182; estudios = 16; calidad moderada); muerte en la infancia (CR 0,68; IC del 95%: 0,36 a 1,27; participantes = 1010; estudios = 4); retraso del neurodesarrollo en la infancia (CR 0,64; IC del 95%: 0,14 a 2,98; participantes = 82; estudios = 1); o muerte en la edad adulta (CR 1,00; IC del 95%: 0,56 a 1,81; participantes = 988; estudios = 1).

processing.... Drugs & Diseases > Protocols Corticosteroid Dose Equivalents  Updated: Mar 29, 2016

  • Author: Abimbola Farinde, PharmD, PhD; more...
  • Share
  • Email
  • Print
  • Feedback
Close
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
Sections Corticosteroid Dose Equivalents
  • Sections Corticosteroid Dose Equivalents
  • Corticosteroid Dose Equivalents
  • Tables
  • References
Corticosteroid Dose Equivalents Corticosteroid dose equivalents are presented in the table below. [ 1 , 2 ]

processing.... Drugs & Diseases > Protocols Topical Corticosteroids  Updated: Aug 19, 2015

  • Author: Abimbola Farinde, PharmD, PhD; more...
  • Share
  • Email
  • Print
  • Feedback
Close
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
Sections Topical Corticosteroids
  • Sections Topical Corticosteroids
  • World Health Organization Classification of Topical Corticosteroids
  • References
World Health Organization Classification of Topical Corticosteroids The potency of a topical corticosteroid depends on the formulation. Potency is also increased when a formulation is used under occlusive dressing or in intertriginous areas. In general, ointments are more potent than creams or lotions. [ 1 ]

Kortikosteroidler

kortikosteroidler

Media:

kortikosteroidlerkortikosteroidlerkortikosteroidlerkortikosteroidlerkortikosteroidler

http://buy-steroids.org